Categories Earnings

American Airlines stock on landing mode after guidance cut

Shares of American Airlines (NYSE: AAL) took a beating on Thursday after the company lowered its guidance for the fiscal year. The company also missed the top-line projection, albeit a small margin.

Hurt by the grounding of Boeing 737 MAX and the ongoing labor contract negotiations, American Airlines said its third-quarter revenues managed to grow a modest 3% to $11.91 billion, missing the street mark of $11.93 billion.

American Airlines Q3 2019 earnings results

Keeping wary of these challenges, the company also slashed its projection on FY19 adjusted EPS to $4.50 – $5.50, compared to the prior estimate of $4.50 – $6.00.

Meanwhile, American Airlines’ Q3 adjusted earnings of $1.42 per share, came in 3 cents above the street consensus.

The stock was trading down 0.5% during pre-market hours on Thursday. The stock has declined 6% in year-to-date period.

READ: Spirit Airlines (SAVE): Q3 2019 Earnings Snapshot

CEO Doug Parker said, “We are pleased to report an earnings increase of 15% and earnings per share growth of 20% for the third quarter, excluding net special items. However, we know that our results should have been better.”

Passenger revenue per available seat mile (PRASM) grew 3% to a 14.50 cents, helped by better load factor during the quarter. TRASM increased by 2%, in line with the management’s projection.

Earlier this month, United Airlines (NASDAQ: UAL) and Delta Air Lines (NYSE: DAL) reported mixed quarterly results.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top